2024
DOI: 10.1002/ajh.27445
|View full text |Cite
|
Sign up to set email alerts
|

Optimal frontline therapy of chronic myeloid leukemia today, and related musings

Hagop M. Kantarjian,
Kebede Begna,
Elias J. Jabbour
et al.

Abstract: The goals of frontline CML-CP therapy; (2) the association of early surrogate response endpoints with these goals; and (3) the treatment value of TKIs (benefit: risk ratio; cost of therapy and what determines drug prices).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 35 publications
0
0
0
Order By: Relevance